NCT05535504

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of repetitive transcranial magnetic stimulation applied with an electromagnetic therapy stimulator 'ALTMS-A' for upper-limb motor function recovery with the sham control group for those who need upper-limb rehabilitation treatment for subcortical and brainstem stroke

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable stroke

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 7, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 10, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

January 2, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 12, 2026

Status Verified

January 1, 2026

Enrollment Period

3 years

First QC Date

September 7, 2022

Last Update Submit

January 8, 2026

Conditions

Keywords

StrokeTranscranial magnetic stimulationRehabilitationNeuronal plasticitySubcortical infarction

Outcome Measures

Primary Outcomes (1)

  • Box and Block test

    Before rTMS (baseline) and 4 weeks after the completion of 10 sessions of rTMS

    upto 42 days

Secondary Outcomes (8)

  • Box and Block test

    upto 14 days

  • Fugl-Meyer Assessment Scale

    upto 42 days

  • modified Barthel Index (the Korean version)

    upto 42 days

  • National Institutes of Health Stroke Scale

    upto 42 days

  • Finger tapping

    upto 42 days

  • +3 more secondary outcomes

Other Outcomes (1)

  • Vital sign

    upto 42 days

Study Arms (2)

real rTMS

EXPERIMENTAL

Use the real rTMS coil

Device: Low-frequency rTMS (experimental)

sham rTMS

SHAM COMPARATOR

Use the sham rTMS coil

Device: Low-frequency rTMS (sham comparator)

Interventions

Frequency: Low-frequency (1Hz) rTMS / Intensity: 100% of resting motor threshold / Location: motor hotspot of the contralesional primary motor cortex (the first dorsal interosseous muscle) / Number of total stimuli : 1800 ; Coil orientation: tangential to scalp

real rTMS

Frequency: Low-frequency (1Hz) rTMS / Intensity: 100% of resting motor threshold / motor hotspot of the contralesional primary motor cortex (the first dorsal interosseous muscle) / Number of total stimuli : 1800 ; Coil orientation: vertical to scalp

sham rTMS

Eligibility Criteria

Age19 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old
  • Radiologically confirmed ischemic stroke with subcortical and brainstem lesions within 90 days
  • Fugl-Meyer assessment scale (upper extremity) \> 15
  • Mini-mental status exam (the Korean version) \> 14 with appropriate cognitive function
  • Written informed consent

You may not qualify if:

  • Fugl-Meyer assessment scale (wrist) \< 1 or Fugl-Meyer assessment scale (hand) \< 1
  • Hemorrhagic stroke or traumatic brain injury
  • Cerebellar stroke
  • Previous history of stroke
  • Traumatic brain injury
  • Previous history of brain surgery
  • Need for intensive care due to complications associated with stroke (e.g. pneumonia, infection, hemodynamic instability)
  • History of psychological or neurological diseases
  • History of pain or muscular weakness of upper limbs which may interfere with rehabilitation
  • History of seizure or epilepsy
  • Aphasia
  • Skin lesions in the stimulation site of scalp
  • Intracranial metal implant
  • Inability to receive regular physical or occupational therapy
  • Disagreement to use contraception in women of childbearing age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital

Seongnam-si, Korea, Gyeonggi-do, 463-707, South Korea

Location

Department of Rehabilitation Medicine, Chungnam National University Hospital, Korea

Daejeon, 35015, South Korea

Location

Related Publications (1)

  • Cho HM, Cha S, Sohn MK, Jee S, Chang WK, Kim WS, Paik NJ. Investigation of the efficacy of low-frequency repetitive transcranial magnetic stimulation on upper-limb motor recovery in subacute ischemic stroke without cortical involvement: a protocol paper for a multi-center, double-blind randomized controlled trial. Front Neurol. 2023 Aug 25;14:1216510. doi: 10.3389/fneur.2023.1216510. eCollection 2023.

MeSH Terms

Conditions

StrokeHemiplegiaCerebral Infarction

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBrain InfarctionBrain IschemiaInfarctionIschemiaPathologic ProcessesNecrosis

Study Officials

  • Nam-Jong Paik, MD, PhD

    Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: ALTMS-A
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 7, 2022

First Posted

September 10, 2022

Study Start

January 2, 2023

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

January 12, 2026

Record last verified: 2026-01

Locations